CTOR
Price
$0.70
Change
-$0.01 (-1.41%)
Updated
Jun 23, 03:59 PM (EDT)
Capitalization
66.37M
56 days until earnings call
Intraday BUY SELL Signals
TKNO
Price
$4.88
Change
-$0.28 (-5.43%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
275.58M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTOR vs TKNO

CTOR vs TKNO Comparison Chart in %
View a ticker or compare two or three
VS
CTOR vs. TKNO commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTOR is a Hold and TKNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (CTOR: $0.71 vs. TKNO: $5.14)
Brand notoriety: CTOR and TKNO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CTOR: 49% vs. TKNO: 250%
Market capitalization -- CTOR: $66.37M vs. TKNO: $275.58M
CTOR [@Pharmaceuticals: Generic] is valued at $66.37M. TKNO’s [@Pharmaceuticals: Generic] market capitalization is $275.58M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTOR’s FA Score shows that 1 FA rating(s) are green whileTKNO’s FA Score has 0 green FA rating(s).

  • CTOR’s FA Score: 1 green, 4 red.
  • TKNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both CTOR and TKNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTOR’s TA Score shows that 4 TA indicator(s) are bullish while TKNO’s TA Score has 4 bullish TA indicator(s).

  • CTOR’s TA Score: 4 bullish, 6 bearish.
  • TKNO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TKNO is a better buy in the short-term than CTOR.

Price Growth

CTOR (@Pharmaceuticals: Generic) experienced а +4.94% price change this week, while TKNO (@Pharmaceuticals: Generic) price change was +24.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.70%. For the same industry, the average monthly price growth was +0.08%, and the average quarterly price growth was +8.31%.

Reported Earning Dates

CTOR is expected to report earnings on Aug 18, 2026.

TKNO is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.70% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKNO($276M) has a higher market cap than CTOR($66.4M). TKNO YTD gains are higher at: 35.263 vs. CTOR (-28.620). TKNO has higher annual earnings (EBITDA): -9.96M vs. CTOR (-41.65M). TKNO has more cash in the bank: 17.8M vs. CTOR (2.63M). CTOR has less debt than TKNO: CTOR (3.8M) vs TKNO (27.8M). TKNO has higher revenues than CTOR: TKNO (41.8M) vs CTOR (5.61M).
CTORTKNOCTOR / TKNO
Capitalization66.4M276M24%
EBITDA-41.65M-9.96M418%
Gain YTD-28.62035.263-81%
P/E RatioN/AN/A-
Revenue5.61M41.8M13%
Total Cash2.63M17.8M15%
Total Debt3.8M27.8M14%
TECHNICAL ANALYSIS
Technical Analysis
CTORTKNO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 6 days ago
63%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 6 days ago
42%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CTOR
Daily Signal:
Gain/Loss:
TKNO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IIVLX21.26N/A
N/A
Transamerica Small/Mid Cap Value C
ASDEX143.55N/A
N/A
American Century Select R6
BDFUX37.25N/A
N/A
Baron Discovery R6
LHCFX22.07N/A
N/A
Lord Abbett Health Care F
ETLCX16.88N/A
N/A
Eventide Large Cap Focus C

CTOR and

Correlation & Price change

A.I.dvisor tells us that CTOR and HIMS have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and HIMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
+6.59%
HIMS - CTOR
21%
Poorly correlated
-5.44%
TKNO - CTOR
16%
Poorly correlated
-1.91%
ZTS - CTOR
13%
Poorly correlated
-3.58%
BFRI - CTOR
11%
Poorly correlated
+10.43%
SHPH - CTOR
10%
Poorly correlated
+1.59%
More